CIRCADIAN RHYTHM
昼夜节律
基本信息
- 批准号:8173612
- 负责人:
- 金额:$ 8.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:Biological AssayBiopsyBlood CellsBlood specimenChemicalsCircadian RhythmsClinicalComputer Retrieval of Information on Scientific Projects DatabaseDataDiseaseFibroblastsFundingGrantHumanInstitutionLuciferasesMeasurementMeasuresMental disordersMetabolic syndromeMonitorPainPathogenesisPatientsPharmacologic SubstancePhysiologicalProceduresRecordsReporter GenesReportingResearchResearch PersonnelResourcesSeasonal Affective DisorderSkinSleep DisordersSourceSubfamily lentivirinaeSystemTechniquesTestingTimeUnited States National Institutes of Healthcell typecircadian pacemakerin vitro Assaymacrophagetime use
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Disturbances in circadian rhythm expression appear to be associated with many diseases, such as seasonal affective disorders, a variety of other mental illnesses, sleep problems, and various metabolic syndromes. Even though associations between circadian rhythm disturbances and several diseases have been reported, the precise mechanisms by which circadian rhythm expression impacts the expression of diseases remain unknown. Among the limiting factors are technical difficulties related to the measurement of human circadian rhythm expression using physiological measures. To better understand human circadian rhythm expression in those patients and the implications of circadian rhythm disturbances in pathogenesis, as well as to evaluate potential pharmaceutical treatments, it is important to develop a non-invasive, simple, rapid and reliable in vitro assay to determine circadian rhythm expression in humans.
One recently-developed technique allows us to obtain high-quality circadian rhythm records in real time, using the circadian clock-luciferase reporter gene and a lentivirus. Furthermore, researchers have demonstrated the feasibility of using skin fibroblasts to record human circadian rhythm expression. However, skin biopsy is not a routine procedure in most clinical departments, and they are painful for patients. Therefore, it would be beneficial to develop an assay system using some other cell types. Our preliminary data suggest that macrophages may be useful in this regard.
In the present proposal, we aim to develop a non-invasive, in vitro assay system to measure human circadian rhythm in macrophages derived from human blood samples, using real-time monitoring of circadian parameters with a clock gene reporter (Aim 1). In addition, this technique will be applied to evaluate the effects of chemicals, thereby testing the feasibility of this assay (Aim 2) are confident to establish such an assay system using human blood cells, and determine the effects of various chemicals on circadian rhythm expression.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目及
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
昼夜节律表达紊乱似乎与许多疾病有关,例如季节性情感障碍、各种其他精神疾病、睡眠问题和各种代谢综合征。尽管昼夜节律紊乱与多种疾病之间的关联已被报道,但昼夜节律表达影响疾病表达的确切机制仍然未知。限制因素包括与使用生理测量测量人类昼夜节律表达相关的技术困难。为了更好地了解这些患者的人类昼夜节律表达以及昼夜节律紊乱在发病机制中的影响,以及评估潜在的药物治疗,开发一种非侵入性、简单、快速和可靠的体外测定来确定昼夜节律非常重要人类的节奏表达。
最近开发的一项技术使我们能够利用生物钟荧光素酶报告基因和慢病毒实时获得高质量的昼夜节律记录。此外,研究人员还证明了使用皮肤成纤维细胞记录人类昼夜节律表达的可行性。然而,皮肤活检并不是大多数临床科室的常规程序,并且给患者带来痛苦。因此,开发使用一些其他细胞类型的测定系统将是有益的。我们的初步数据表明巨噬细胞在这方面可能有用。
在本提案中,我们的目标是开发一种非侵入性体外测定系统,通过时钟基因报告基因实时监测昼夜节律参数,测量来自人类血液样本的巨噬细胞的人类昼夜节律(目标1)。此外,该技术将应用于评估化学物质的影响,从而测试该测定的可行性(目标2)有信心建立这样的利用人体血细胞的测定系统,并确定各种化学物质对昼夜节律表达的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHIAKI FUKUHARA其他文献
CHIAKI FUKUHARA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHIAKI FUKUHARA', 18)}}的其他基金
DIFFERENTIAL IN VITRO LITHIUM RESPONSES IN BIPOLAR PATIENTS
双相情感障碍患者体外锂反应的差异
- 批准号:
8359903 - 财政年份:2011
- 资助金额:
$ 8.6万 - 项目类别:
IDENTIFICATION OF BIOMARKERS FOR LITHIUM SENSITIVITY IN BIPOLAR DISORDERS
双相情感障碍中锂敏感性生物标志物的鉴定
- 批准号:
8173614 - 财政年份:2010
- 资助金额:
$ 8.6万 - 项目类别:
IN VITRO DIAGNOSTIC TEST FOR LITHIUM-SENSITIVE BIPOLAR DISORDER
锂敏感双相情感障碍的体外诊断测试
- 批准号:
8173613 - 财政年份:2010
- 资助金额:
$ 8.6万 - 项目类别:
相似国自然基金
利用三维卷积神经网络挖掘超声内镜成像特征精准引导胰腺癌细针穿刺活检的辅助诊断模型
- 批准号:82373118
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
肿瘤外泌体核酸甲基化标志物的鉴定及其在液体活检中的应用
- 批准号:22307101
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
近红外二区比率荧光双探针对转移前哨淋巴结的时间分辨活检
- 批准号:82302254
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于明场微视觉动态三维感知的胚胎活检微纳操作机器人导引关键技术研究
- 批准号:52305023
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于Aptamer修饰的3D-DNA网络CTC捕获技术在液态活检中的转化研究
- 批准号:82330065
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
相似海外基金
Endogenous synthesis of TRAIL by glioma cancer stem cells and resistance to TRAIL therapy
胶质瘤干细胞内源合成 TRAIL 及对 TRAIL 治疗的耐药性
- 批准号:
10863308 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
- 批准号:
10820331 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别:
T-cell activation and exhaustion in the HIV-positive female genital tract
HIV 阳性女性生殖道中 T 细胞的激活和耗竭
- 批准号:
10704271 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别:
Improving response prediction to neoadjuvant therapy in pancreatic cancer
改善胰腺癌新辅助治疗的反应预测
- 批准号:
10784272 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别:
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches
利用先进的蛋白糖组学、放射组学和基因组学方法在诊断时识别致命的前列腺癌
- 批准号:
10718530 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别: